Radiotherapy for metastatic bone disease: current standards and future prospectus

Area of Science:

• Oncology
• Radiotherapy
• Palliative Care

Background:

• Population dynamics necessitate increased end-of-life cancer care.
• Palliative radiotherapy is crucial for managing advanced cancer symptoms.
• Painful bone metastases are a common indication for palliative radiotherapy.

Purpose of the Study:

• To review current and future strategies for palliative radiotherapy in bone metastases.
• To discuss the role of various treatment modalities, including single-fraction, stereotactic body radiotherapy, and radiopharmaceuticals.
• To highlight the importance of clinical guidelines and resource allocation in future developments.

Main Methods:

• Review of current clinical practices and emerging technologies in palliative radiotherapy for bone metastases.
• Discussion of surgical interventions for specific complications like fractures and spinal cord compression.
• Consideration of systemic treatments like injectible radiopharmaceuticals and hemibody radiation.

Main Results:

• Single-fraction radiotherapy is effective, efficient, and cost-effective for bone metastases.
• Stereotactic body radiotherapy shows promise for spine metastases but requires further definition of its niche.
• Surgery is indicated for pathologic fractures, instability, or cord compression.
• Radiopharmaceuticals and hemibody radiation can treat multiple painful sites.

Conclusions:

• Palliative radiotherapy is a cornerstone in managing painful bone metastases.
• Future developments will be shaped by resource allocation, clinical guidelines, and technological integration.
• A multidisciplinary approach is essential for optimal end-of-life cancer care.